Literature DB >> 19962479

Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.

Ri-Bo Tang1, Xiao-Hui Liu, Jérôme Kalifa, Zhi-An Li, Jian-Zeng Dong, Ya Yang, Xing-Peng Liu, De-Yong Long, Rong-Hui Yu, Chang-Sheng Ma.   

Abstract

This study sought to assess the impact of body mass index (BMI) on the risk of left atrial (LA)/left atrial appendage (LAA) thrombus in patients with atrial fibrillation (AF) before catheter ablation. From January 2007 to March 2008, 433 consecutive patients with nonvalvular AF were enrolled. Patients with valvular heart disease, deep vein thrombosis, or pulmonary embolism were excluded. All patients underwent transesophageal echocardiography. Twenty-six of 433 patients (6.0%) had LA/LAA thrombus and the patients with thrombus had a significantly higher BMI (27.9 +/- 3.1 vs 26.0 +/- 3.3 kg/m(2), p = 0.005). The area under the receiver operating characteristic curve of BMI predicting thrombus was 0.662. With a cut-off point of 27.0 kg/m(2), the sensitivity and specificity of BMI for the diagnosis of thrombus were 69.2% and 83.1%, respectively. The incidence of LA/LAA thrombus was 10.6% in patients with BMI > or =27.0 kg/m(2) versus only 3.0% for patients with BMI <27.0 kg/m(2) (p = 0.001). In multivariable analysis, BMI > or =27.0 kg/m(2) (odds ratio 4.02, 95% confidence interval 1.19 to 13.55, p = 0.025), Cardiac Failure, Hypertension, Age, Diabetes, Stroke Doubled score > or =2, and nonparoxysmal AF were independent risk factors of LA/LAA thrombus. In conclusion, BMI > or =27.0 kg/m(2) is an independent risk factor of LA/LAA thrombus in patients with AF.

Entities:  

Mesh:

Year:  2009        PMID: 19962479      PMCID: PMC2894707          DOI: 10.1016/j.amjcard.2009.07.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 2.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

3.  Obesity and the risk of new-onset atrial fibrillation.

Authors:  Thomas J Wang; Helen Parise; Daniel Levy; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

4.  [Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch].

Authors:  Yan-hui Lu; Ju-ming Lu; Shu-yu Wang; Chun-lin Li; Li-sheng Liu; Run-ping Zheng; Hui Tian; Xian-ling Wang; Li-juan Yang; Yu-qing Zhang; Chang-yu Pan
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-02-14

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Sekar Kathiresan; Jian Rong; Daniel Levy; John F Keaney; Thomas J Wang; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

7.  Associations of haemostatic variables with body mass index: a community-based study.

Authors:  Louise K Bowles; Jackie A Cooper; David J Howarth; George J Miller; Peter K MacCallum
Journal:  Blood Coagul Fibrinolysis       Date:  2003-09       Impact factor: 1.276

8.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

9.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

10.  Association between obesity and a prothrombotic state: the Framingham Offspring Study.

Authors:  Guido A Rosito; Ralph B D'Agostino; Joseph Massaro; Izabella Lipinska; Murray A Mittleman; Patrice Sutherland; Peter W F Wilson; Daniel Levy; James E Muller; Geoffrey H Tofler
Journal:  Thromb Haemost       Date:  2004-04       Impact factor: 5.249

View more
  11 in total

Review 1.  Association Between BMI and QoL Improvement in AF Patients Following Catheter Ablation.

Authors:  Martin Martinek; Helmut Purerfellner
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 2.  Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 3.  Stroke prevention in atrial fibrillation: atrial appendage closure.

Authors:  Cindy J Fuller; Mark Reisman
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

4.  Relationship between body mass index and left atrial appendage thrombus in nonvalvular atrial fibrillation.

Authors:  Kevin P Cohoon; Robert D McBane; Naser Ammash; Joshua P Slusser; Diane E Grill; Waldemar E Wysokinski
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

5.  Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.

Authors:  Juan Wang; Yan-min Yang; Jun Zhu; Han Zhang; Xing-hui Shao; Li Tian; Bi Huang; Li-tian Yu; Xin Gao; Man Wang
Journal:  Clin Res Cardiol       Date:  2014-02-18       Impact factor: 5.460

6.  Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.

Authors:  Hai-Jun Wang; Quan-Jin Si; Zhao-Liang Shan; Yu-Tao Guo; Kun Lin; Xiao-Ning Zhao; Yu-Tang Wang
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Atrial thrombi in elective patients considered for atrial fibrillation rhythm control: Risk factors and prognostic value.

Authors:  Marcella Cabral Caires; Roberto Muniz Ferreira; Thaís Fonseca Rodrigues; David Hong Kang; Lúcia Helena Alvares Salis; Nelson Albuquerque de Souza E Silva
Journal:  Indian Heart J       Date:  2021-01-29

Review 8.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

9.  Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation.

Authors:  Rui Providência; Ana Faustino; Luís Paiva; Andreia Fernandes; Sérgio Barra; Joana Pimenta; Joana Trigo; Ana Botelho; António M Leitão-Marques
Journal:  BMC Cardiovasc Disord       Date:  2013-06-10       Impact factor: 2.298

10.  Incidence and Predictors of Intracardiac Thrombus on Pre-electrophysiological Procedure Transesophageal Echocardiography.

Authors:  Mohamed Al Rawahi; Michelle Samuel; Christos Galatas; Jacqueline Joza; Pedro Y Lima; Rodrigo Barbosa; George Thanassoulis; Martin L Bernier; Thao Huynh; Vidal Essebag
Journal:  CJC Open       Date:  2019-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.